The central tension in the investment case is that MCB's reported profitability has already peaked (PAT down 9% from the 2023 high), yet the share price has rallied 43% over the last twelve months. The just-released Q1 2026 consolidated PAT of Rs. 13.14 bn was down 11% year-on-year, confirming that NIM compression from the SBP's easing cycle is now biting the reported numbers.Read more